Agatsa wins Aegis Graham bell award for smallest ECG device- Sanket Life

New Delhi (India), March 8: Agatsa, a healthcare technology company founded by an Electronics Engineer Duo Rahul Rastogi and Neha Rastogi, has won the prestigious Aegis Graham Bell Award in the ‘Best Innovation in Diagnostics’ category. The company’s flagship product Sanket Life is an IoT platform that consists of a portable and touch-based digital ECG machine that has been designed to make heart health screening easier and more affordable for everyone a smartphone app and a state-of-the-art cloud. The device is equivalent in medical accuracy to hospital-grade ECG machines and is 1/10th the size and cost. It can be carried in a pocket anywhere and can be operated by anyone with minimal or no training. The device was adjudged as the best in its category, beating competition from giants like Siemens Healthineers and mFine. Agatsa has its own algorithm of not just capturing ECG and displaying, recording the ECG graph on a smartphone but it also has its AI algorithms to interpret that graph and give the first-level interpretation. It has its own state-of-the-art cloud to save all the reports for future reference.

Aegis Graham Bell Awards (AGBA) is an initiative Aegis School of Data Science, Cyber Security, and Telecommunication to recognize the talent who has the potential to grow as technology leaders; start-up founders; innovators; entrepreneurs; intra entrepreneurs who are transforming the lives of millions of Indians by their work. The 12th AGBA is supported by the Ministry of Electronics and Information Technology, Government of India; Skill India’ NIC (National Informatics Centre, office under the Ministry of Electronics and Information Technology). Hon’ble Minister Dr. Ram Lal Markanda, Hon’ble Minister Dr. Rajkumar Ranjan Singh & Sardar R. P. Singh felicitated the founder of Agatsa Rahul Rastogi and the entire Agatsa team for being recognized as the Winner under Innovative Diagnostic Solution.

Agatsa is currently working on integrating Sanket Life with advanced AI to provide advanced cardiac diagnostics and to aid medical professionals with a portable, digital tool equipped with the highest tech like AI and Blockchain. This will make it possible to detect heart disease at a very early stage and will help both the healthcare professionals and the patients to monitor and manage their hearts easily. Currently, Sanket Life is being sold on online ecommerce platforms like Amazon, Flipkart and its own website. Agatsa is also rapidly scaling to B2B partnerships with Digital health companies who can integrate their device into their platforms and tying up with hospitals, diagnostic labs, and small clinics for its products and ECG review services.

When asked about the feeling after winning the coveted Graham Bell Awards Agatsa CEO, Mr. Rahul Rastogi said “We are thrilled to receive this award. This is like a noble prize for innovations in different areas which can also be commercialized and help people in general. This award is given after much grilling and validates all the hard work and years of research to develop a product like Sanket Life which is the FIRST in the world. We are happy that our product is not just adopted by the users and the patients but also by the doctors PAN India. Not just it is adopted it is very much appreciated. Our best influencers have been our customers who are using the products.

Agatsa also appreciated government support in recognizing homegrown innovations which are Made in India, made for the world! There is no device in the world which is as Small as Sanket Life and can take medical grade 12-Lead ECG just by touching the pen-like device at different points. It is medically approved in cardiac institutes like Narayana Hrudayala and Sri Jayadeva institute of Cardiavascular Science and Research with an accuracy of 99%. It is an ISO-13485 compliant organization with researching, designing and manufacturing its devices in India itself.

Aegis award is not the first prestigious award won by Agatsa. Agatsa has won many powerful awards like Anjani Mashelkar award for Inclusive innovation, Marico Innovation Award, Millenium Alliance, Frost & Sullivan Award, TiE BiRAC WiNER award awarded to women entrepreneur in biological research and awards 25Lacs INR to the best Women Entrepreneurs. Agatsa co-founder Neha Rastogi is also listed in a list of 20 most Audacious women in Forbes India.

Agatsa launched a useful multi-parameter device during the Covid which could monitor multi parameters – ECG monitor, Spo2, and Temperature with just a touch. There are many in the cost of one device people were getting four parameters. The complete technology is very frugal and affordable which scales down costs. Our products range begins from INR 2,500 with different options and comes with a one-year replacement warranty.

Business

Texas Smokehouse secures funding, set to open 100 outlets in its first phase of expansion in India

Chandigarh [India], February 14: Texas Smokehouse, India’s first-ever smoked chicken QSR brand, is making bold moves to disrupt the country’s fast-food industry. Yummify Foods & Beverages Pvt Ltd, the parent company of Texas Smokehouse, has raised undisclosed funding in a pre-seed round. The founder, Isht Sethi, has announced an aggressive expansion plan of 100 outlets; […]

Read More
Business

‘Bharat Tex 2025 Set To Be A Game Changer’ , Bhadresh Dodhia , Chairman, MATEXIL

Mumbai (Maharashtra) [India], February 13:  Bharat Tex 2025, India’s largest and most comprehensive textile event, is set to take place from February 14 to 17, 2025, at Bharat Mandapam, New Delhi. Speaking on the significance of the event, Shri Bhadresh Dodhia, Chairman of MATEXIL and Co-Chairman of the Core Committee for Bharat Tex 2025, said […]

Read More
Business

Spright Agro’s Q3 Revenue Surges 142%, Net Profit Up By 28.9%

Ahmedabad (Gujarat) [India], February 11: Spright Agro Limited (BSE: 531205), a leading company in the agriculture sector specialising in contract farming and greenhouse technology, has announced excellent financial results for the third quarter of the financial year 2024-25, showcasing exceptional growth in revenue and profitability. For the quarter ended December 2024, the company reported a […]

Read More